Anniina Snellman

Effect of genotype and age on cerebral [F-18]FDG uptake varies between transgenic APP(swe)-PS1(dE9) and Tg2576 mouse models of Alzheimer's disease (2019)

Scientific Reports

Anniina Snellman, Jatta S. Takkinen, Francisco R. López-Picón, Olli Eskola, Olof Solin, Juha O. Rinne, Merja Haaparanta-Solin

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Long-Term Monoacylglycerol Lipase Inhibitor Treatment Decelerates Pathological Changes in APP/PS1-21 Mice, but Behavioral Improvements Require Early-Stage Treatment Onset—Short Report (2018)

World Journal of Neuroscience

Rea Pihlaja, Noora Lindgren, Annamari Torittu, Anniina Snellman, Merja Haaparanta-Solin, Juha O. Rinne

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer's Disease (2018)

Scientific Reports

Daniele Tolomeo, Edoardo Micotti, Sonia Colombo Serra, Michael Chappell, Anniina Snellman, Gianluigi Forloni

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Neuroinflammation appears early and then plateaus in a mouse model of Alzheimer's disease shown by PET imaging (2018)

Journal of Nuclear Medicine

Francisco R. López-Picón, Anniina Snellman, Olli Eskola, Semi Helin, Olof Solin, Merja Haaparanta-Solin, Juha O. Rinne

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

[F-18]FMPEP-d(2) PET imaging shows age- and genotype-dependent impairments in the availability of cannabinoid receptor 1 in a mouse model of Alzheimer's disease (2018)

Neurobiology of Aging

Jatta S. Takkinen, Francisco R. López-Picón, Anna K. Kirjavainen, Rea Pihlaja, Anniina Snellman, Tamiko Ishizu, Eliisa Löyttyniemi, Olof Solin, Juha O. Rinne, Merja Haaparanta-Solin

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Applicability of [C-11]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model (2017)

Neurobiology of Aging

Snellman A, Rokka J, Lopez-Picon FR, Helin S, Re F, Löyttyniemi E, Pihlaja R, Forloni G, Salmona M, Masserini M, Solin O, Rinne JO, Haaparanta-Solin M

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Imaging Alzheimer’s Disease Beta-amyloid Pathology in Transgenic Mouse Models Using Positron Emission Tomography (2017)

Snellman Anniina

(Artikkeliväitöskirja (G5))

Increased striatal VMAT2 binding in mice after chronic administration of methcathinone and manganese (2016)

Brain Research

Asser A, Kõks S, Snellman A, Haaparanta-Solin M, Arponen E, Grönroos T, Nairismägi J, Bergquist J, Soomets U, Piip P, Eltermaa M, Sauk M, Lindmäe H, Rinne JO, Taba P.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ex Vivo Tracing of NMDA and GABA-A Receptors in Rat Brain After Traumatic Brain Injury Using F-18-GE-179 and F-18-GE-194 Autoradiography (2016)

Journal of Nuclear Medicine

Lopez-Picon F, Snellman A, Shatillo O, Lehtiniemi P, Gronroos TJ, Marjamaki P, Trigg W, Jones PA, Solin O, Pitkanen A, Haaparanta-Solin M

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

F-18-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease (2016)

European Journal of Pharmaceutical Sciences

Rokka J, Snellman A, Kaasalainen M, Salonen J, Zona C, La Ferla B, Nicotra F, Re F, Masserini M, Forsback S, Lopez-Picon F, Rinne JO, Haaparanta-Solin M, Solin O

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Effect of genotype and age on cerebral [F-18]FDG uptake varies between transgenic APP(swe)-PS1(dE9) and Tg2576 mouse models of Alzheimer's disease (2019)

Long-Term Monoacylglycerol Lipase Inhibitor Treatment Decelerates Pathological Changes in APP/PS1-21 Mice, but Behavioral Improvements Require Early-Stage Treatment Onset—Short Report (2018)

Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer's Disease (2018)

Neuroinflammation appears early and then plateaus in a mouse model of Alzheimer's disease shown by PET imaging (2018)

[F-18]FMPEP-d(2) PET imaging shows age- and genotype-dependent impairments in the availability of cannabinoid receptor 1 in a mouse model of Alzheimer's disease (2018)

Applicability of [C-11]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model (2017)

Imaging Alzheimer’s Disease Beta-amyloid Pathology in Transgenic Mouse Models Using Positron Emission Tomography (2017)

Increased striatal VMAT2 binding in mice after chronic administration of methcathinone and manganese (2016)

Ex Vivo Tracing of NMDA and GABA-A Receptors in Rat Brain After Traumatic Brain Injury Using F-18-GE-179 and F-18-GE-194 Autoradiography (2016)

F-18-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease (2016)